JPH0345064B2 - - Google Patents
Info
- Publication number
- JPH0345064B2 JPH0345064B2 JP57127795A JP12779582A JPH0345064B2 JP H0345064 B2 JPH0345064 B2 JP H0345064B2 JP 57127795 A JP57127795 A JP 57127795A JP 12779582 A JP12779582 A JP 12779582A JP H0345064 B2 JPH0345064 B2 JP H0345064B2
- Authority
- JP
- Japan
- Prior art keywords
- formula
- oxo
- pyrrolidinyl
- ethyl
- hydroxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH4849/81A CH647234A5 (en) | 1981-07-24 | 1981-07-24 | Pyrrolidine derivatives |
CH4849/81-6 | 1981-07-24 | ||
CH2768/82-3 | 1982-05-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5824558A JPS5824558A (ja) | 1983-02-14 |
JPH0345064B2 true JPH0345064B2 (cs) | 1991-07-09 |
Family
ID=4283624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP57127795A Granted JPS5824558A (ja) | 1981-07-24 | 1982-07-23 | ピロリジン誘導体 |
Country Status (10)
Country | Link |
---|---|
JP (1) | JPS5824558A (cs) |
KR (1) | KR890000768B1 (cs) |
BR (1) | BR8204328A (cs) |
CH (1) | CH647234A5 (cs) |
ES (1) | ES8404678A1 (cs) |
GR (1) | GR76177B (cs) |
IS (1) | IS2742A7 (cs) |
MW (1) | MW2682A1 (cs) |
PL (1) | PL138918B1 (cs) |
ZA (1) | ZA825104B (cs) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH666891A5 (de) * | 1985-11-26 | 1988-08-31 | Lonza Ag | 4-alkoxy-2-oxo-pyrrolidin-1-yl-essigsaeure-c(1)-c(4)-alkylester, deren herstellung und verwendung. |
KR100498268B1 (ko) * | 1997-12-09 | 2005-11-01 | 주식회사 엘지생활건강 | 피롤리돈계 양쪽성 계면활성제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2923975A1 (de) * | 1979-06-13 | 1980-12-18 | Nattermann A & Cie | Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel |
-
1981
- 1981-07-24 CH CH4849/81A patent/CH647234A5/de not_active IP Right Cessation
-
1982
- 1982-06-22 IS IS2742A patent/IS2742A7/is unknown
- 1982-07-12 MW MW26/82A patent/MW2682A1/xx unknown
- 1982-07-16 ZA ZA825104A patent/ZA825104B/xx unknown
- 1982-07-22 GR GR68825A patent/GR76177B/el unknown
- 1982-07-23 JP JP57127795A patent/JPS5824558A/ja active Granted
- 1982-07-23 BR BR8204328A patent/BR8204328A/pt unknown
- 1982-07-23 KR KR8203307A patent/KR890000768B1/ko not_active Expired
- 1982-07-23 PL PL1982237634A patent/PL138918B1/pl unknown
-
1983
- 1983-03-22 ES ES520820A patent/ES8404678A1/es not_active Expired
Also Published As
Publication number | Publication date |
---|---|
CH647234A5 (en) | 1985-01-15 |
PL138918B1 (en) | 1986-11-29 |
ES520820A0 (es) | 1984-05-16 |
BR8204328A (pt) | 1983-07-19 |
GR76177B (cs) | 1984-08-03 |
ES8404678A1 (es) | 1984-05-16 |
JPS5824558A (ja) | 1983-02-14 |
KR840000489A (ko) | 1984-02-22 |
IS2742A7 (is) | 1983-01-25 |
PL237634A1 (en) | 1984-01-30 |
KR890000768B1 (ko) | 1989-04-05 |
MW2682A1 (en) | 1984-03-14 |
ZA825104B (en) | 1983-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5972936A (en) | Benzofuran carboxamides and their therapeutic use | |
TWI568448B (zh) | 四級銨鹽前藥 | |
BE1006343A5 (fr) | Derives de l'indole. | |
US5034402A (en) | Methods and pharmaceutical compositions using pyrrolidine derivatives | |
AU710825B2 (en) | Quinolones and their therapeutic use | |
CN102573471A (zh) | 新的吡咯烷衍生的β3肾上腺素受体激动剂 | |
AP877A (en) | Tetrahydroquinoline derivatives as EAA antagonists. | |
KR0178469B1 (ko) | 흥분성 아미노산 길항제 | |
KR20000053274A (ko) | 이환식 아릴 카르복사미드 및 그의 치료학적 용도 | |
KR840001551B1 (ko) | 시클로헥센 유도체의 제조방법 | |
JPH0354097B2 (cs) | ||
US5792774A (en) | Quinolones and their therapeutic use | |
JPH0345064B2 (cs) | ||
US6331556B2 (en) | Heterocyclic compounds and their therapeutic use | |
KR850000845B1 (ko) | 피롤리딘 유도체의 제조방법 | |
KR20010005567A (ko) | 퀴놀린-2-카르복실산 유도체 및 그의 흥분성 아미노산 길항제로서의 용도 | |
KR890000767B1 (ko) | 피롤리딘 유도체의 제조방법 | |
KR850000844B1 (ko) | 피롤리딘 유도체의 제조방법 | |
JPH0233029B2 (ja) | Pirorijinjudotai | |
CZ340599A3 (cs) | Derivát kyseliny chinolin-2-karboxylové | |
FR2764291A1 (fr) | Derives de 5-naphtalen-1-yl-1,3-dioxane, leur preparation et leur application en therapeutique |